To investigate the molecular characteristics of H3N2 canine influenza viruses circulating in Jiangsu, China, we isolated a H3N2 strain (A/Canine/Nanjing/CnNj01-2025) from a dog presenting with respiratory signs at the Veterinary Teaching Hospital of Nanjing Agricultural University. All eight gene segments were sequenced and compared with those of two human H3N2 strains and five avian H3N2 strains. Antigenicity and receptor-binding properties were also assessed. Phylogenetic analysis revealed that the canine isolate descended from the avian lineage and formed an independent evolutionary clade, while the human strains were more distantly related to the avian lineage. Glycosylation analysis of the HA protein revealed that the canine strain carried seven N-glycosylation sites, including a unique site at residue 97/81 (HA/H3 numbering), which serves as a molecular signature of the canine strain. Several amino-acid substitutions were identified in major antigenic sites, including D97/81N, A176/160T, N204/188D, V212/196I, and W237/222L. Analysis of internal genes showed that the canine strain harbored PB2 292T and 590S mammalian adaptation mutations, which are also present in human strains. Hemagglutination inhibition (HI) assays of the canine strain indicated moderate serologic cross-reactivity with a human H3N2 antiserum (16-fold reduction), whereas avian strains showed no cross-reactivity. Receptor-binding assays demonstrated that the virus retained predominant α-2,3 sialic acid binding, comparable to that of avian influenza viruses, and gained a modest affinity for human-type α-2,6 sialic acid receptors. Therefore, the canine H3N2 virus has undergone significant antigenic drift, developed partial serological cross-reactivity with human strains, and acquired detectable but limited binding affinity for human-type receptors. Overall, our findings suggest that the current canine H3N2 influenza virus exhibits distinct genetic and antigenic variations from human and avian strains. Continuous molecular and serological surveillance of canine influenza viruses is therefore warranted to monitor their evolutionary trends and assess the potential for cross-species transmission.
15 October 2025 in Frontiers in Veterinary Science
Objectives: This study aimed to evaluate the survival and survivor characteristics in cats diagnosed with feline aortic thromboembolism (FATE) who underwent surgical aortic thrombectomy.Methods: Medical records from 2021 to 2023 were retrospectively reviewed for cats diagnosed with FATE that underwent surgical aortic thrombectomy. Data collected included signalment, medical history, clinical examination findings, laboratory parameters before and after surgery, the time from FATE onset to surgery, treatments administered, survival to discharge, and recurrence or long-term outcomes in discharged cats.Results: Thirteen client-owned cats met the inclusion criteria. Common postoperative laboratory abnormalities observed during hospitalization included azotemia (n = 8), anemia (n = 4), hyperkalemia (n = 4), and elevated alanine aminotransferase (n = 3). After surgery, 53.8% of the cats survived to discharge, with 71.4% showing complete recovery of hind limb motor function. Among the discharged cats, two (28.6%) were confirmed deceased during follow-up, while five (71.4%) were lost to follow-up. The median follow-up duration was 37 days (14–498). Recurrence of FATE occurred in two cats (28.6%) at 77 and 493 days postoperatively; both were successfully managed with medical treatment and survived to discharge again. Cats that survived had significantly lower preoperative neutrophil-to-lymphocyte ratios (p = 0.033), postoperative serum potassium levels (p = 0.037), and postoperative blood urea nitrogen concentrations (p = 0.037) than non-survivors.Conclusion and relevance: Cats undergoing surgical aortic thrombectomy for FATE showed a 53.8% survival rate to discharge, with 71.4% of survivors achieving full recovery of limb motor function. Surgical aortic thrombectomy may be considered as a treatment option for cats with FATE, particularly when timely presentation allows for early intervention.